s6y

REVELATION BIOSCIENCES, INC.

Ticker
REVB, REVBW
CIK
1810560
Industry
Pharmaceutical Preparations
Formerly
Petra Acquisition Inc.

Financials 33

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q/A Quarterly Report for period ending Jun 30, 2024

All 33 financials filings

News 101

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 101 news filings

Ownership 100

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 100 ownership filings

Prospectus 57

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-3 Registration statement for specified transactions by certain issuers
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-3/A Registration statement for specified transactions by certain issuers
  7. S-3 Registration statement for specified transactions by certain issuers
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-1/A General form of registration statement for all companies including face-amount certificate companies
  10. S-1 General form of registration statement for all companies including face-amount certificate companies

All 57 prospectus filings

Proxies 30

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

All 30 proxies filings

Other 69

  1. SCHEDULE 13G/A
  2. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  3. SCHEDULE 13G
  4. ARS Annual report to security holders
  5. SCHEDULE 13G/A
  6. EFFECT Notice of Effectiveness
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. UPLOAD Letter (PDF)
  9. SCHEDULE 13G
  10. SCHEDULE 13G

All 69 other filings